跳至主要内容
临床试验/ACTRN12616000300471
ACTRN12616000300471进行中(未招募)未知

Safety and efficacy of automated targeting of oxygen therapy in premature infants

Menzies Institute for Medical Research, University of Tasmania0 个研究点目标入组 60 人开始时间: 2016年3月8日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
o limit 至 4 Months(—)
性别
All

入选标准

  • i) Preterm birth at <32 weeks gestation
  • ii) Requirement for non-invasive respiratory support, including continuous positive airway pressure (CPAP), or high flow via nasal cannula (HF).
  • iii ) Either a) requirement for supplemental oxygen at the time of commencing the study, or b) in room air but showing a propensity to hypoxic events with or without apnoea.
  • iv) Research team available to commence recording.

排除标准

  • Currently ventilated or in imminent need of intubation and ventilation

研究者

发起方
Menzies Institute for Medical Research, University of Tasmania

相似试验